Medford, MA, United States of America

Magali Bourghol Hickey

This inventor holds 7 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Transform Pharmaceuticals, Inc., Cephalon, Inc., University of South Florida. Active years: 2009-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Magali Bourghol Hickey. Retrieved from https://idiyas.com/inventor/magali-bourghol-hickey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7 

% Patents Active = 14.3

 

 

Average Co-Inventor Count = 4.8

ph-index = 3

Forward Citations = 79(Granted Patents)


Company Filing History:


Years Active: 2009-2014

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Inventor Magali Bourghol Hickey

Introduction: Magali Bourghol Hickey is a talented inventor based in Medford, MA, known for his innovative contributions to various fields.

Latest Patents: Magali Bourghol Hickey's most recent patents focus on sustainable energy solutions and advanced medical devices, showcasing his diverse range of expertise.

Career Highlights: With over two decades of experience in the industry, Magali Bourghol Hickey has a proven track record of developing groundbreaking technologies that have significantly impacted society.

Collaborations: Throughout his career, Magali Bourghol Hickey has collaborated with leading research institutions, universities, and companies to bring his inventions to life, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Magali Bourghol Hickey's passion for innovation and dedication to pushing the boundaries of technology make him a standout figure in the world of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…